LINC01060

Across TCGA pan-cancer cohorts, LINC01060 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC01060’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01060 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01060 is over-expressed in tumor, although a few such as KICH and KIRP show the opposite, repressed pattern.

HNSC, KICH, and KIRP are the cancer types where LINC01060 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01060 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.225	<.001	10	view →
KICH	All	II,III,IV	−0.851	<.001	7	view →
KIRP	Male	All	−0.760	<.001	7	view →
BRCA	All	III,IV	−0.521	<.001	6	view →
STAD	Male	All	+0.172	.016	4	view →
COAD	All	All	+0.078	.025	4	view →
BLCA	Female	III,IV	+0.135	.009	3	view →
LUSC	Female	III,IV	+0.110	.031	3	view →
LIHC	All	All	+0.103	.022	3	view →
KIRC	Female	All	+0.488	.043	2	view →
PAAD	Female	All	+0.154	.005	2	view →
PRAD	All	All	+0.121	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC01060–HNSC

Open the HNSC breakdown →